CME Group Inc. $CME Shares Bought by BI Asset Management Fondsmaeglerselskab A S

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BI Asset Management Fondsmaeglerselskab A S increased its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 427.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,879 shares of the financial services provider's stock after purchasing an additional 60,672 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in CME Group were worth $19,865,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter worth about $25,000. Cornerstone Planning Group LLC grew its holdings in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares during the period. Golden State Wealth Management LLC grew its holdings in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares during the period. Alpine Bank Wealth Management purchased a new stake in CME Group in the 1st quarter valued at about $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new stake in CME Group in the 1st quarter valued at about $32,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insider Activity at CME Group

In related news, Director William R. Shepard purchased 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the transaction, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director directly owned 4,900 shares in the company, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent analyst reports. Barclays set a $298.00 price target on CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Citigroup lifted their price target on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Piper Sandler lifted their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Finally, Oppenheimer lifted their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $261.93.

CME Group Stock Down 1.4%

CME Group stock traded down $3.80 during midday trading on Friday, hitting $269.52. 1,591,589 shares of the company were exchanged, compared to its average volume of 1,923,555. The company's fifty day moving average price is $275.82 and its 200-day moving average price is $268.31. The company has a market cap of $97.13 billion, a PE ratio of 26.09, a price-to-earnings-growth ratio of 4.95 and a beta of 0.44. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $206.44 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the company posted $2.56 EPS. On average, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's payout ratio is 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.